• Produkte > Peripher

    iCOVER HAS RECEIVED CE-MARK!
    iVascular has announced that the company has received CE-mark for their new balloon-expandable ePTFE covered stent!

  • Produkte > Peripher

    TINTIN Trial
    TINTIN is a physician initiated, prospective, single arm multicenter trial, that investigates the safety and efficacy of the treatment with luminor DCB and iVolution self-expanding stent in TASC C and D femoropopliteal lesions. TINTIN 1-year outcomes show a Primary Patency of 90.5%, freedom from TLR of 94.4%. Safety has been proved with 0 device related deaths.
    weiterlesen

  • News

    EFFPAC: 42-MONTH OUTCOMES
    EFFPAC RCT 42-month outstanding results with Luminor DCB have been revealed at LINC 2021.
    weiterlesen

  • Produkte > Peripher

    SERGEANT
    sergeant is a peripheral support catheter, designed to lead complex lesions procedures. It is intended to provide physicians with the needed support to cross all lesions. sergeants outstanding guidewire support is possible thanks to its braided catheter that allows exceptional pushability and torque capacity and tapered shaft that increases the support.
    weiterlesen

Endoscout

WER WIR SIND

endoscout mit Firmensitz in Freiburg ist ein innovatives und global vernetztes Unternehmen im Bereich der Medizintechnik.

Das Unternehmen gliedert sich in die beiden Geschäftsbereiche endotrade, dem Direktvertrieb interventioneller Produkte, sowie dem Geschäftsbereich endocare in dem endoscout als Full-Service-Dienstleister in den Bereichen Einkauf, Logistik und Abrechnung auf dem Gebiet der ambulanten Behandlung tätig ist.

weiterlesen

Produkte Interventionelle Gefäßtherapie

Peripher

Produkte Interventionelle Gefäßtherapie

Koronar

NEWS

Analysis of German Insurance Data Shows No Long-Term Increased Mortality With Paclitaxel-Based Devices

A real-world analysis of 9.2 million patients included in a German insurance database showed no evidence for increased mortality associated with paclitaxel-based drug-eluting devices (DEDs) during 11 years of use in endovascular revascularization (EVR) of peripheral vessels
weiterlesen

NEWS

Two-year Review on Mortality and Morbidity after Femoropopliteal Drug-coated Balloon Angioplasty in the Randomized EffPac Trial

Extended safety review including patients who were lost to follow-up at 2 years revealed no evidence of an increased risk of all-cause mortality after femoropopliteal drug-coated balloon angioplasty.
weiterlesen

 

Mediathek

Produktinformationen, Produktkatalog und vieles mehr finden Sie hier zum Download
weiterlesen

 

Kontakt

Schreiben Sie uns, oder rufen Sie uns an, wir sind für Sie da. Oder vereinbaren Sie einfach einen Termin.
E-Mail

Messe, Workshops

50. Jahrestagung der DGA

30.09.2021 – 02.10.2021 in Berlin

50. Jahrestagung der DGA und 5. DGA-Interventionskongress

Alle Events anzeigen